[ad_1]
The US Food and Drug Administration. (FDA) has issued an alert on the health dangers of blood transfusions from young donors, such as anti-aging treatments or diseases such as Parkinson's disease, multiple sclerosis or Alzheimer's disease , statement issued Tuesday by the said government agency.
"The FDA recently learned that plasma infusions from young donors are being offered in multiple states to likely treat the effects of a number of conditions," the message says, noting that these conditions include normal aging and memory loss. face serious diseases such as dementia, Parkinson's disease, multiple sclerosis, Alzheimer's disease, heart deficits and post-rhythmic stress. "
The text stresses that not only there is no proven clinical benefit treating these conditions through blood transfusions of young donors, but this can lead to health problems, and note that these treatments have not been approved by the FDA and that they "are potentially harmful". He also points out that these practices – which, he says, cost thousands of dollars – often lead people in need to avoid other, safer treatments.
After reading the FDA announcement, the company Ambrosia, operating in five US cities and accused $ 8,000 for a liter of blood of this type and 12,000 for two, he ceased his activities, as indicated on his website.
Source link
